Screener

Eligibility screening

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Sponsored by National Institute of Mental Health (NIMH)Study detailsClinicalTrials.gov

1 US site in MD

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.